Surgical Robotics Technology
Intuitive announces financial results for the quarter ended December 31, 2022.
Q4 Highlights
- Worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2021. The fourth quarter of 2022 reflected a resurgence in COVID-19 in China, which negatively impacted procedure volumes in the region.
- The fourth quarter of 2021 also reflected COVID-19 disruptions later in the quarter in the U.S. and Europe, which impacted our procedures. The compound annual growth rate between the fourth quarter of 2019 and the fourth quarter of 2022 was approximately 14%.
- The Company placed 369 da Vinci Surgical Systems, a decrease of 4% compared with 385 in the fourth quarter of 2021.
- The Company grew its da Vinci Surgical System installed base to 7,544 systems as of December 31, 2022, an increase of 12% compared with 6,730 as of the end of the fourth quarter of 2021.
- Fourth quarter 2022 revenue of $1.66 billion increased 7% compared with $1.55 billion in the fourth quarter of 2021.
- Fourth quarter 2022 GAAP net income attributable to Intuitive was $325 million, or $0.91 per diluted share, compared with $381 million, or $1.04 per diluted share, in the fourth quarter of 2021.
- Fourth quarter 2022 non-GAAP* net income attributable to Intuitive was $439 million, or $1.23 per diluted share, compared with $473 million, or $1.29 per diluted share, in the fourth quarter of 2021.
- The Company repurchased $1 billion of common stock in the fourth quarter of 2022.
For a full summary, please visit: https://isrg.intuitive.com/news-releases/news-release-details/intuitive-announces-fourth-quarter-earnings-2
Source: Intuitive
